Showing results (261-270 of 455) with videos related to
Sort By:
Pageof 46
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2007
Outcomes of dosage adjustments used to manage antiretroviral drug interactionsLaura Y Park-Wyllie, Mitchell A Levine, Anne Holbrook, et al.BMJ (Clinical Research Ed.)|September 14, 2011
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control studyTony Antoniou, Tara Gomes, Muhammad M Mamdani, et al.Circulation. Cardiovascular Quality and Outcomes|June 29, 2012
Clinical evidence, practice guidelines, and β-blocker utilization before major noncardiac surgeryDuminda N Wijeysundera, Muhammad Mamdani, Andreas Laupacis, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 21, 2024
Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, OntarioMary Aglipay, Jeffrey C Kwong, Karen Colwill, et al.Circulation|February 9, 2011
IScore: a risk score to predict death early after hospitalization for an acute ischemic strokeGustavo Saposnik, Moira K Kapral, Ying Liu, et al.BMC Health Services Research|October 22, 2011
Narcotic analgesic utilization amongst injured workers: using concept mapping to understand current issues from the perspectives of physicians and pharmacistsJanet A Parsons, Muhammad Mamdani, Onil Bhattacharyya, et al.BMJ Open Quality|October 26, 2021
Harnessing the full potential of hospital-based data to support surgical quality improvementSean Nicholas Leung, Mohammed Al-Omran, Elisa Greco, et al.JAMA Surgery|April 7, 2016
Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial DiseaseMohamad A Hussain, Mohammed Al-Omran, Muhammad Mamdani, et al.Clinical Pharmacology and Therapeutics|May 25, 2021
Trends in Postpartum Opioid Prescribing: A Time Series AnalysisJonathan S Zipursky, Andrea Pang, J Michael Paterson, et al.Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|January 17, 2012
Immunologic effectiveness of maraviroc- and raltegravir-containing regimens (R+M+) versus raltegravir-based regimens that do not include maraviroc (R+M-)Tony Antoniou, Graham Smith, Desheng Su, et al.Pageof 46